𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of HIV-1 primary resistance among HIV chronically infected patients in Brazil's Southeast region

✍ Scribed by C.M.P.M. Soares; T.R.C. Vergara; M.M. Caseiro; R. Côrtes; B. Scarpellini; M.C.A. Sucupira; R.S. Diaz

Book ID
118451452
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
71 KB
Volume
14
Category
Article
ISSN
1201-9712

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An in-house HIV genotyping assay for the
An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1
✍ Chun Kiat Lee; Hong Kai Lee; Tze Ping Loh; Sunil Kumar Sethi; Evelyn Siew-Chuan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Genotyping for HIV drug resistance is costly and beyond the means for many Southeast Asian patients, who are self‐funded. This prompted the development of a more cost‐effective, in‐house assay for an ethnically diverse, Southeast Asian population at the National University Hospital in S

Low prevalence of transmitted drug resis
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia
✍ Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as

Prevalence of drug resistant mutants and
Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection
✍ Tamalet, Catherine; Pasquier, Christophe; Yahi, Nouara; Colson, Philippe; Poizot 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Baseline genotype resistance analysis was carried out in 48 adults with primary HIV-1 infection between 1995 and 1998 before starting early combination therapy. Seventeen percent (8/48) of the isolates displayed key mutations conferring resistance to reverse transcriptase (RT) inhibitors such as ami